• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.57% Nasdaq Up 0.16%

    Isis Pharmaceuticals, Inc. (ISIS)

    -NasdaqGS
    53.02 Down 1.38(2.54%) 12:17PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:54.40
    Open:54.66
    Bid:53.29 x 200
    Ask:53.33 x 100
    1y Target Est:68.78
    Beta:2.27
    Next Earnings Date: 4-Aug-15ISIS Earnings announcement
    Day's Range:53.00 - 54.87
    52wk Range:29.17 - 77.80
    Volume:756,410
    Avg Vol (3m):2,377,970
    Market Cap:6.35B
    P/E (ttm):N/A
    EPS (ttm):-0.21
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ISIS

    Comparison

    Symbol% ChgMkt Cap
    ISISDown 2.54%6.35B
    ENZUp 1.33%140.02M
    GILDUp 2.86%170.92B
    SRPTDown 1.00%1.31B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):26.20
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.32
    Quarterly EPS Est (Jun-15) :0.29
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):-7.38

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product includes the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients with... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback